Menu
Close
Consumer and Product Liability

The Final Cass Report was published in April 2024, over three and a half years later and two years after her Interim Report was published. The purpose...

Listening to those we represent describing their lives with a failed medical product can be harrowing, but helping them access justice is a remarkable...

Puberty supressing hormones will no longer be routinely offered as a treatment for gender dysphoria in children and adolescents according to new NHS England...

The Supreme Court has passed a landmark judgment setting out an approach for secondary victims claiming for psychiatric harm in a clinical negligence...

Pogust Goodhead has this month launched our newest initiative, 'My Finance Claim'. Its purpose is to hold lenders and brokers to account whilst securing...

Michigan has repealed a blanket immunity law for drugmakers. This law had hindered the rights of residents for decades, preventing them from addressing...

NHS Healthcare Improvement Scotland (HIS) have been ordered by the Scottish Government to report on the service provided at Sandyford clinic for the treatment...

Pogust Goodhead continues to fight for individuals who have been injured by the iron deficiency anemia drug, Injectafer. Injectafer was brought to the...

On 5 January 2022, the Paris Judicial Tribunal (Tribunal Judiciaire de Paris)[1] ruled for the first time since group actions were introduced into French...
No posts found